Nobel Prize Recognizes Groundbreaking Body's Defenses Research

The prestigious award in medical science was awarded for transformative findings that illuminate how the immune system attacks dangerous pathogens while sparing the healthy tissues.

A trio of renowned researchers—Japan's Shimon Sakaguchi and American experts Mary Brunkow and Fred Ramsdell—received this accolade.

The research uncovered unique "security guards" within the immune system that eliminate rogue defense cells that could attacking the organism.

The findings are now paving the way for innovative therapies for autoimmune diseases and malignancies.

These winners will share a monetary award valued at 11m SEK.

Crucial Findings

"The research has been essential for understanding how the immune system functions and why we do not all develop serious autoimmune diseases," stated the chair of the Nobel Committee.

This team's studies address a fundamental mystery: How does the defense system protect us from numerous invaders while leaving our healthy cells unharmed?

The immune system uses immune cells that scan for signs of infection, even viruses and bacteria it has not met before.

These defenders utilize sensors—called receptors—that are generated by chance in countless combinations.

That gives the defense network the ability to combat a broad range of invaders, but the randomness of the process unavoidably creates white blood cells that can target the body.

Security Guards of the Immune System

Scientists previously knew that some of these harmful defense cells were destroyed in the immune organ—where immune cells develop.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the immune system's "peacekeepers"—which travel through the system to disarm other defenders that attack the healthy cells.

It is known that this process fails in self-attack conditions such as juvenile diabetes, multiple sclerosis, and rheumatoid arthritis.

The Nobel panel added, "The discoveries have established a new field of research and spurred the creation of innovative therapies, for instance for cancer and immune disorders."

Regarding malignancies, regulatory T-cells prevent the system from fighting the tumor, so research are aimed at reducing their quantity.

In self-attack disorders, trials are exploring boosting T-reg cells so the body is no longer under attack. A comparable method could also be useful in reducing the chances of transplanted organ rejection.

Pioneering Studies

Professor Shimon Sakaguchi, from Osaka University, performed tests on mice that had their thymus extracted, leading to self-attack conditions.

He showed that introducing defense cells from healthy animals could stop the illness—implying there was a mechanism for blocking immune cells from attacking the body.

Dr. Brunkow, affiliated with the Institute for Systems Biology in Seattle, and Fred Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in rodents and humans that resulted in the discovery of a gene vital for how T-regs function.

"Their groundbreaking research has revealed how the body's defenses is kept in check by regulatory T cells, preventing it from mistakenly attacking the body's own tissues," said a prominent biological science expert.

"This research is a striking example of how basic physiological research can have broad consequences for human health."